Top 10 Stock Picks of Jeffrey Diehl's Adams Street Partners
In this article, we will be taking a look at the top 10 stock picks of Jeffrey Diehl's Adams Street Partners.
Corvus Pharmaceuticals Inc. (CRVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 6,943,654 | $6,875 | 0.12% | |
| 2. | Tang Capital Management Kevin C. Tang | 3,301,709 | $3,269 | +7% | 0.49% |
| 3. | Millennium Management Israel Englander | 2,687,943 | $2,661 | -2% | 0% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,370,947 | $1,357 | 0.06% | |
| 5. | Renaissance Technologies Jim Simons | 962,932 | $953 | +7% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 5,000 | Officer, Director | 1,349,405 | 2022-06-27 | Filing | |
| $1.03 | 5,000 | Officer, Director | 1,344,405 | 2022-06-24 | Filing | |
| $1.01 | 890 | Officer, Director | 1,339,405 | 2022-06-06 | Filing | |
| $0.97 | 170 | Officer, Director | 1,338,515 | 2022-06-02 | Filing | |
| $0.98 | 4,830 | Officer, Director | 1,338,345 | 2022-06-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.96 | 2,000,000 | Large Shareholder | 81,077 | 2021-10-01 | Filing | |
| $5.04 | 3,000,000 | Large Shareholder | 2,081,077 | 2021-09-30 | Filing | |
| $6.09 | 1,109,644 | Large Shareholder, Director | 6,943,654 | 2021-09-20 | Filing | |
| $6.09 | 1,109,644 | Large Shareholder, Director | 6,943,654 | 2021-09-20 | Filing | |
| $5.37 | 741,440 | Large Shareholder | 1,389,498 | 2020-07-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 2,214,184 | $2,192 | 0.83% | |
| 2. | 1,267,752 | $1,255 | 0% | |
| 3. | 1,224 | $1,212 | 0% | |
| 4. | 505,566 | $501 | 0% | |
| 5. | 500,000 | $495 | 0.02% |
News See All
Why These 5 Stocks Are On the Move on Friday
5. United States Steel Corporation (NYSE:X) is around 8% lower today after the company provided a third quarter update.
Hedge Fund and Insider Trading News: Warren Buffett, Bill Ackman, Ken Griffin, Crispin Odey, Anthony Scaramucci, Corvus Pharmaceuticals Inc (CRVS), Carnival Corp (CCL), and More
A historic economic comeback is sending some of the world’s biggest investors bargain hunting in the unloved energy sector.
Should You Buy Corvus Pharmaceuticals, Inc. (CRVS)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Aren't Crazy About Corvus Pharmaceuticals, Inc. (CRVS) Anymore
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
Hedge Fund and Insider Trading News: Larry Robbins, Point72 Asset Management, NII Holdings (NIHD), Marchex, Inc. (MCHX), Corvus Pharmaceuticals Inc (CRVS), and More
Larry Robbins is a hedge fund manager and CEO of Glenview Capital Management. He is also well known for his quarterly letters to investors.
13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
Hedge Fund and Insider Trading News: Starboard Value LP, Two Sigma, Rev Group Inc (REVG), Church & Dwight Co., Inc. (CHD), Pfizer Inc. (PFE), and More
(Reuters) - Starboard Value LP, which is looking to replace the entire board of Newell Brands Inc (NWL.N), said on Wednesday three of its nominees would buy about $25 million in Newell stock with their...
Falling Stocks: What is Going on With Corvus Pharmaceuticals Inc (CRVS)?
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) shares have fallen 50% in mid-day trading after the company announced interim results from an ongoing phase 1/1b study demonstrating safety and clinical activity...
Billionaire Hedge Funds
